Scientists at Trinity College Dublin have discovered a new process in our immune systems that leads to the production of an ...

More than 200 viruses can infect and cause disease in humans; most of us will be infected by several over the course of a ...

New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking approval for an experimental medication for the neurological condition.

The company plans to use the Series B investment to advance the development of its macrophage therapies in inflammatory and ...

Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases. In healthy tissues ...

Researchers have created a map of human skin that uses genomics and other technologies to understand how skin forms and the ...

A higher abundance of monocyte-derived alveolar macrophages significantly correlated with worse lung fibrosis in RPRA ...

Circadian rhythms of macrophages are altered by conditions associated with the tumor microenvironment, including acidic pH. This may be responsible for the heterogeneity in circadian clock gene ...

India's focus on tuberculosis research, including antimicrobial resistance, Mtb survival mechanisms, and potential new ...

Despite being a remarkable medical advancement, organ transplants still face the critical issue of rejection by the immune ...